(2024). Pyrazoline B-Paclitaxel or Doxorubicin Combination Drugs Show Synergistic Activity Against Cancer Cells: In silico Study. Advances and Applications in Bioinformatics and Chemistry.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Pyrazoline B-Paclitaxel or Doxorubicin Combination Drugs Show Synergistic Activity Against Cancer Cells: In Silico Study."
Advances and Applications in Bioinformatics and Chemistry 2024.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Pyrazoline B-Paclitaxel or Doxorubicin Combination Drugs Show Synergistic Activity Against Cancer Cells: In Silico Study."
Advances and Applications in Bioinformatics and Chemistry, 2024.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.